During the past decade, Università degli Studi Federico II; Clinica di Oncologia Medica conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 10 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università degli Studi Federico II; Clinica di Oncologia Medica" #1 collaborator was "University of Campania "Luigi Vanvitelli"" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Università degli Studi Federico II; Clinica di Oncologia Medica" are "Breast Cancer" (9 trials), "Colorectal Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials) and "Advanced Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Università degli Studi Federico II; Clinica di Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Università degli Studi Federico II; Clinica di Oncologia Medica" are "Drug" (23 trials), "Procedure" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Placebo" (4 trials), "Trastuzumab" (4 trials), "Trastuzumab Emtansine" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Università degli Studi Federico II; Clinica di Oncologia Medica" are 19 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Università degli Studi Federico II; Clinica di Oncologia Medica". undefined are not yet recruiting, 2 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Università degli Studi Federico II; Clinica di Oncologia Medica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Università degli Studi Federico II; Clinica di Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".